Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Clinical utility of novel biomarkers in acute myocardial infarction
Thomas Stiermaier
,
Holger Thiele
, Ingo Eitel
*
*
Corresponding author for this work
Clinic of Internal Medicine II - Cardiology
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical utility of novel biomarkers in acute myocardial infarction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Biological Marker
100%
Acute Heart Infarction
100%
Cardiac Troponin
53%
Heart Muscle Injury
19%
Non ST Segment Elevation Myocardial Infarction
19%
Risk Stratification
11%
Acute Coronary Syndrome
11%
Myocardial Infarction
11%
Natriuretic Factor
11%
Clinical Decision Making
7%
Health Care Cost
7%
Cardiac Magnetic Resonance Imaging
7%
Heart Muscle Necrosis
7%
Heart Left Ventricle Function
7%
Troponin
7%
Growth Differentiation Factor 15
7%
Sensitivity and Specificity
3%
Echocardiography
3%
Atrial Fibrillation
3%
Takotsubo Cardiomyopathy
3%
Endothelial Dysfunction
3%
Fibrosis
3%
Coronary Artery Disease
3%
microRNA
3%
Clinical Finding
3%
Thrombocyte Activation
3%
Diagnostic Performance
3%
Clinical Endpoint
3%
ST Segment Elevation Myocardial Infarction
3%
Creatine Kinase MB
3%
Hemodynamic
3%
Adiponectin
3%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Acute Heart Infarction
100%
Troponin
61%
Copeptin
23%
Heart Muscle Injury
19%
Heart Infarction
11%
Natriuretic Factor
11%
Acute Coronary Syndrome
11%
Inflammation
7%
Growth Differentiation Factor 15
7%
Galectin 3
3%
Creatine Kinase
3%
Kidney Disease
3%
Fibrosis
3%
microRNA
3%
Atrial Fibrillation
3%
Adiponectin
3%
ST Segment Elevation Myocardial Infarction
3%
Creatine Kinase MB
3%
Biochemistry, Genetics and Molecular Biology
Growth Differentiation Factor
14%
Heart Left Ventricle Function
14%
Hemodynamic Stress
14%
Troponin
14%
MicroRNA
7%
Hemodynamic
7%
Galectin-3
7%
Magnetic Resonance Imaging
7%
Isoenzyme
7%
Blood Clot Lysis
7%
Tissue Characterization
7%
Thrombocyte Activation
7%
Atrial Fibrillation
7%
Immunology and Microbiology
Natriuretic Peptide
21%
Troponin
14%
Heart Left Ventricle Function
14%
Growth Differentiation Factor 15
14%
Coronary Artery
7%
Magnetic Resonance Imaging
7%
Muscle Cell
7%
Galectin 3
7%
Thrombocyte Activation
7%
Hemodynamic
7%
Adiponectin
7%